1.
Metabolic syndrome and cardiovascular risk in patients with breast cancer undergoing adjuvant endocrine therapy. Acervo Saúde [Internet]. 2026 Mar. 17 [cited 2026 Nov. 3];26(3):e23208. Available from: https://acervomais.com.br/saude/article/view/23208